<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TB R&#38;D Matters Blog &#187; innovations</title>
	<atom:link href="http://www.newtbdrugs.org/blog/tag/innovations/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.newtbdrugs.org/blog</link>
	<description>Working Towards a Faster Cure for Tuberculosis</description>
	<lastBuildDate>Sat, 19 May 2012 12:57:01 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Watch Video from the World TB Day Congressional Briefing</title>
		<link>http://www.newtbdrugs.org/blog/watch-video-from-the-world-tb-day-congressional-briefing/</link>
		<comments>http://www.newtbdrugs.org/blog/watch-video-from-the-world-tb-day-congressional-briefing/#comments</comments>
		<pubDate>Tue, 01 May 2012 18:02:10 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[aeras]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[usa]]></category>
		<category><![CDATA[usaid]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3780</guid>
		<description><![CDATA[A briefing and update on tuberculosis (TB), a disease that is curable but still takes the lives of 4,000 people each day and is the number one killer of people living with HIV.  Links to video included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/watch-video-from-the-world-tb-day-congressional-briefing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Community Engagement through Drama</title>
		<link>http://www.newtbdrugs.org/blog/community-engagement-through-drama/</link>
		<comments>http://www.newtbdrugs.org/blog/community-engagement-through-drama/#comments</comments>
		<pubDate>Tue, 17 Apr 2012 17:16:46 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Faces of TB]]></category>
		<category><![CDATA[TB Patient Perspective]]></category>
		<category><![CDATA[TB R&D Spotlight Interviews]]></category>
		<category><![CDATA[TB Stigma]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[WGND Podcast Series]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[community engagement]]></category>
		<category><![CDATA[education]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[podcast]]></category>
		<category><![CDATA[social impact]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[tb/hiv]]></category>
		<category><![CDATA[voices]]></category>
		<category><![CDATA[youth empowerment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3729</guid>
		<description><![CDATA[Dr. Gill Black is the co-founder and Director of Health and Welfare at The Sustainable Livelihoods Foundation (SLF).  In this inteview, we discuss with Dr. Black one of SLF's groundbreaking projects that uses drama to engage local communities around issues related to TB and HIV/AIDS.  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/community-engagement-through-drama/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Update: Strategies for Early and Late Stage Drug Development</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-update-strategies-for-early-and-late-stage-drug-development/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-update-strategies-for-early-and-late-stage-drug-development/#comments</comments>
		<pubDate>Wed, 11 Apr 2012 19:13:03 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[global health]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3704</guid>
		<description><![CDATA[This week, we are highlighting two articles published online in the Journal of Infectious Diseases in March.  The first article by Coxon, et al., looks at the benefits and limitations of the two main approaches to compound discovery for TB, target-based and phenotypic-based.  The second article by Phillips, et al., would like TB clinical trialists to consider new strategies or designs for evaluating TB drug regimens which could alleviate a bottleneck as new drugs and consequently new potential drug combinations move into clinical testing.  Additional links to TB R&#038;D publications and news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-update-strategies-for-early-and-late-stage-drug-development/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>World TB Day!  Overview of Events, News and Messages</title>
		<link>http://www.newtbdrugs.org/blog/world-tb-day-overview-of-events-news-and-messages/</link>
		<comments>http://www.newtbdrugs.org/blog/world-tb-day-overview-of-events-news-and-messages/#comments</comments>
		<pubDate>Fri, 23 Mar 2012 18:53:40 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[vaccines]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[world tb day]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3614</guid>
		<description><![CDATA[Saturday, March 24, is officially World TB Day but there has been a stream of activities, publications, news and messages to let the world not forget about this major infectious disease killer that claims millions of lives each year.  We present links and summaries of events, publications, messages, and news coverage leading up to World TB Day.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/world-tb-day-overview-of-events-news-and-messages/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  CSU Identifies Anti-TB Compound against Unique Target</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-csu-identifies-anti-tb-compound-against-unique-target/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-csu-identifies-anti-tb-compound-against-unique-target/#comments</comments>
		<pubDate>Thu, 23 Feb 2012 21:45:26 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[Funding Opportunities]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[usa]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3502</guid>
		<description><![CDATA[This week's article highlights research out of Colorado State University that identifies a potential anti-TB compound against a unique target-- the inner membrane transporter MmpL3 of Mycobacterium tuberculosis--that inhibits an essential cell function of the mycobacteria.  Additional links to TB R&#038;D News are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-csu-identifies-anti-tb-compound-against-unique-target/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Innovative Professional Development Resource for Clinical Researchers and More</title>
		<link>http://www.newtbdrugs.org/blog/innovative-professional-development-resource-for-clinical-researchers-and-more/</link>
		<comments>http://www.newtbdrugs.org/blog/innovative-professional-development-resource-for-clinical-researchers-and-more/#comments</comments>
		<pubDate>Tue, 14 Feb 2012 21:58:23 +0000</pubDate>
		<dc:creator>Tamzin_Furtado</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[career development]]></category>
		<category><![CDATA[clinical research]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[global health]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[networks]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[professional development]]></category>
		<category><![CDATA[resource tool]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3484</guid>
		<description><![CDATA[We would like to share an exciting development in the field of global health, which has been launched in the last six months – an innovative professional membership scheme for tracking the continued professional development of clinical research staff across all types of trials and all regions.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/innovative-professional-development-resource-for-clinical-researchers-and-more/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  Tailoring TB Treatment Based on Host Genotype?</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tailoring-treatment-based-on-host-genotype/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tailoring-treatment-based-on-host-genotype/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 22:40:47 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[Life Cycle of Tuberculosis]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[animal models]]></category>
		<category><![CDATA[host-targeting]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[zebra fish]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3466</guid>
		<description><![CDATA[This week we have research out of the Ramakrishnan Laboratory that challenges thinking around tuberculosis treatment and considerations of host genotypes.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tailoring-treatment-based-on-host-genotype/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>News from the 21st Stop TB Partnership Coordinating Board Meeting, Bangkok</title>
		<link>http://www.newtbdrugs.org/blog/news-from-the-21st-stop-tb-partnership-coordinating-board-meeting-bangkok/</link>
		<comments>http://www.newtbdrugs.org/blog/news-from-the-21st-stop-tb-partnership-coordinating-board-meeting-bangkok/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 19:37:16 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[TAG]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3455</guid>
		<description><![CDATA[he 21st Stop TB Partnership Coordinating Board retreat and meeting officially started in Bangkok, Thailand, on Sunday, January 29th with the official opening ceremony held yesterday January 30th. Included are some exciting news from the meeting courtesy of Mark Harrington, Executive Director of the Treatment Action Group (TAG). ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/news-from-the-21st-stop-tb-partnership-coordinating-board-meeting-bangkok/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  SQ109 and PNU Compounds Additive</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-sq109-and-pnu-compounds-additive/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-sq109-and-pnu-compounds-additive/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 21:53:44 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[combination therapy]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[new drugs]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3432</guid>
		<description><![CDATA[In this week's article, we look at two drugs in our Global TB Drug Pipeline and how they interact with each other:  SQ109 (class: Ethylenediamines, Sequella) and PNU-100480 (called Sutezolid, class: Oxazolidinone, Pfizer).  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-sq109-and-pnu-compounds-additive/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  TDR Tuberculosis Strain Bank</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tdr-tuberculosis-strain-bank/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tdr-tuberculosis-strain-bank/#comments</comments>
		<pubDate>Fri, 20 Jan 2012 21:02:08 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Early Drug Development]]></category>
		<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB Diagnostics]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[database]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[drug discovery]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[research tool]]></category>
		<category><![CDATA[resource]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[TDR]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3420</guid>
		<description><![CDATA[This week we highlight an article looking at the TDR Tuberculosis Strain Bank and its utility.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tdr-tuberculosis-strain-bank/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

